If you’re feeling depressed and looking for a solution, there are many options: medications, CBT, DBT, somatic therapy and so ...

A recent study suggests that mindfulness-based stress reduction (MBSR) may be as effective as certain medications in ...

While analysts still see value in Alto’s approach to brain drugmaking, investors may have lost some faith, as the biotech’s ...

Depression is a common but serious mood disorder that can affect how a person feels, thinks, and handles their daily activities. It can be a confusing disorder to understand because there are ...

The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...

The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.

Drug maker Granules India on Friday said it has received approval from the US health regulator to market a generic medication to treat major depressive disorder. The company has received approval from ...

What we're seeing is that this drug has a fairly benign safety profile.” Supernus is aiming to share data from the phase 2b trial, which is testing SPN-820 in treatment-resistant depression (TRD ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder. Granules said it has now a total of 67 ANDA approvals from the ...

I know that SSRIs can be a real mixed bag; I'm one of the lucky one-third who has never achieved "remission." Taking an SSRI ...

Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...